Dr Jay mentioned Dr Tom Carmichael (UCLA) and his work on using small molecule approaches to block CCR five post-CVA events. I’ve read the studies with Maraviroc Over the years for other indications and often thought they are a roadmap for us to pursue other indications moving forward. It appears Dr. J is seeing things the same way.

https://www.cell.com/cell/fulltext/S0092-8674%2819%2930107-2

https://ctv.veeva.com/study/maraviroc-to-augm...ter-stroke

https://neurobio.ucla.edu/people/s-thomas-carmichael-md-phd

https://abc7.com/stroke-drug-aids-treatment-f...h/5364563/